Vichapat Tharanon Theerasuk Kawamatawong
10.1177/2050313X221118200
SAGE Open Med Case Rep
2022 Aug 19;10:2050313X221118200.
subtherpeutic anti-factor xa levels ascites bioavailability subcutaneous enoxaparin
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/36003894/
Case Reports
PMC9393492
36003894
Critically ill patients with edema and ascites may experience subtherapeutic anti-factor Xa levels following abdominal subcutaneous enoxaparin treatment
2022